Evidence map›Paper›PMID 38716424›Full record

ArticleCase reports in neurological medicine2024

Novel SLC18A2 Variant in Infantile Dystonia-Parkinsonism Type 2.

Sakari Kaasalainen, Harri Arikka, Mika H Martikainen, Valtteri Kaasinen

Abstract readCase Reports
In one paragraph

Article in Case reports in neurological medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Identification of a NovelCase reports in neurological medicine · 2026
    Article
  2. Review
  3. Novel SLC18A2 Variant in Infantile Dystonia-Parkinsonism Type 2.Case reports in neurological medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sakari KaasalainenClinical Neurosciences, University of Turku, Turku, Finland.
Harri ArikkaDepartment of Pediatric Neurology, Turku University Hospital, Turku, Finland.
Mika H MartikainenClinical Neurosciences, University of Turku, Turku, Finland.ORCID https://orcid.org/0000-0002-7604-8081
Valtteri KaasinenClinical Neurosciences, University of Turku, Turku, Finland.ORCID https://orcid.org/0000-0002-3446-7093

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infantile dystonia-parkinsonism type 2 (PKDYS2) is a rare inherited autosomal recessive movement disorder with onset in infancy. The disease is associated with a mutation in the solute carrier family 18 member A2 gene (

Identifiers

PMID38716424
PMCPMC11074866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.